01 Oct 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Sanofi has appointed Dr Paul Chew as senior vice president, chief medical officer and head of Global Medical Affairs as of January 1, 2013.
Dr Chew, currently senior vice president, chief science officer and chief medical officer at Sanofi, US, will succeed Mr Jean-Pierre Lehner, who will retire on December 31, 2012, after more than 20 years of dedicated service to the company. Dr Chew will report to Dr Elias Zerhouni, president, Global Research & Development, and will be based in Bridgewater, NJ and Paris, France.
"Jean-Pierre dedicated his career to the well-being of patients and the success of the Group," said Mr Christopher A Viehbacher, chief executive officer, Sanofi. "Throughout his impressive and diversified career, Jean-Pierre has made significant and lasting contributions to improve public health and has been a key contributor to Sanofi's success."
Jean-Pierre Lehner joined the Group in 1992 and was appointed to positions of increasing responsibility before starting in his current position in 2009.
"The knowledge and experience Paul has gained through his previous roles, including his work as a cardiologist, his expertise in diabetes and work within R&D make him ideally suited for this important role and continue the medical excellence which Jean-Pierre instilled within our organization," said Dr Elias Zerhouni, president, Global Research & Development.